Should You Combine PRP and Hyaluronic Acid Injections for Knee Arthritis?
- 14 hours ago
- 5 min read
By Dr. Jeffrey Peng, MD · Published March 6, 2026 · 6 min read
Watch the Full Video
Both hyaluronic acid (HA) injections and platelet-rich plasma (PRP) injections are well-established treatments for knee osteoarthritis. When used individually, head-to-head trials consistently show that PRP tends to produce more favorable outcomes than HA alone. But a growing body of research is now exploring whether combining the two injections could produce a synergistic effect — offering patients even better pain relief and functional improvement than either treatment on its own.
The short answer? The science behind the idea is compelling, but the clinical evidence is still evolving. Here is what the current data shows and how I approach this question in my practice.
How Do PRP and Hyaluronic Acid Work Differently?
Understanding why researchers are interested in combining these two treatments requires understanding how each one works on its own.
PRP exerts primarily a biologic effect. It delivers a concentrated dose of growth factors and cytokines directly into the joint, targeting the degenerative microenvironment of an arthritic knee. PRP reduces inflammatory markers, promotes tissue repair signaling, and may help slow the progression of cartilage breakdown.
Hyaluronic acid works primarily through a mechanical effect. It acts as a viscosupplement — restoring lubrication and cushioning within the joint space. HA also has a lesser biologic effect, reducing friction-related irritation and providing some anti-inflammatory benefit through different molecular pathways than PRP.
Both treatments share anti-inflammatory properties, but they achieve this through distinct mechanisms. This is the core rationale for combination therapy: by targeting as many degenerative and inflammatory pathways as possible, the hope is that patients will experience greater and longer-lasting symptom relief.
What Is the Rationale for Combining PRP and HA?
The theoretical framework for combining PRP and HA is straightforward. PRP addresses the biologic component of osteoarthritis — the inflammatory cytokines, the growth factor deficits, the cellular signaling dysfunction. HA addresses the mechanical component — the loss of joint lubrication, the increased friction between degraded cartilage surfaces.
By administering both treatments together, clinicians hope to cover a wider range of the degenerative pathways that drive symptoms in knee osteoarthritis. In theory, this multimodal approach should yield better results than either injection alone. The question is whether the clinical trials support this theory.
What Does the Clinical Evidence Show?
A randomized controlled trial by Xu et al. compared PRP alone, HA alone, and PRP combined with HA in 122 knees. At both 6 and 12 months, synovial hyperplasia improved in the PRP and PRP-plus-HA groups. Inflammatory markers — including interleukin-1β, TNF-α, and matrix metalloproteinases — decreased in both groups, with more pronounced reductions in the combination group. At 24 months, pain and function scores in the PRP-plus-HA group were significantly better than in either monotherapy group. The authors concluded that PRP combined with HA was more effective at inhibiting synovial inflammation while improving pain and function.
A systematic review and meta-analysis by Zhao et al. pooled data from 7 studies (941 patients) comparing PRP-plus-HA with PRP or HA alone. They found that the combination improved WOMAC function scores, WOMAC total scores, 6-month VAS pain ratings, and Lequesne Index scores compared to PRP alone — with no significant difference in adverse event rates.
However, a systematic review by Baria et al. published in The American Journal of Sports Medicine analyzed 8 studies and reached a different conclusion. They found that combination therapy improved patient-reported outcomes and was superior to HA alone — but was not superior to PRP alone. Of the studies that used PRP as the control, four out of four showed no additional benefit from adding HA.
Why Do Two Meta-Analyses Reach Different Conclusions?
This is one of the more interesting aspects of this topic. The Zhao et al. and Baria et al. reviews only had two overlapping studies in their analyses, despite examining the same clinical question. Their inclusion criteria differed significantly.
The Zhao meta-analysis did not include two randomized controlled trials that showed no benefit of combination therapy over PRP alone. Meanwhile, the Baria review did not include four other studies that potentially showed benefits of the combined approach. These differences in study selection explain why the two reviews reached divergent conclusions from largely non-overlapping evidence bases.
This is a good reminder that systematic reviews are only as strong as their search strategies and inclusion criteria. When you see conflicting meta-analyses on the same topic, the first thing to examine is which primary studies each one included — and which ones were left out.
How I Currently Approach PRP and HA in My Practice
Based on the current evidence, I am not yet convinced that combining PRP and hyaluronic acid in a single injection session provides a meaningful advantage over PRP alone. The science behind the concept is sound, but the clinical trial data is mixed, and more research is needed before we can make definitive claims.
What I currently recommend to my patients is to consider both treatments, but rather than combining them simultaneously, stagger them over time. In my practice, PRP injections remain the primary treatment for controlling symptoms, reducing pain, and improving function during an arthritic knee flare. Once we have successfully managed the acute flare, the goal shifts to maintaining that improvement with a long-term management program.
That maintenance program may include regular booster PRP injections and, in some cases, staggering them with hyaluronic acid injections. The idea is to keep the arthritic joint environment as balanced and healthy as possible over the long term — using each treatment where it is most effective rather than mixing everything together at once.
Of course, this approach may evolve as new clinical trials are published. If future high-quality randomized controlled trials demonstrate a clear benefit to simultaneous combination therapy, I will update my recommendations accordingly. If you are interested in learning more about a comprehensive, multimodal approach to managing knee osteoarthritis, explore the rest of my content or schedule a consultation.
References
1. Xu Z, He Z, Shu L, Li X, Ma M, Ye C. Intra-Articular Platelet-Rich Plasma Combined With Hyaluronic Acid Injection for Knee Osteoarthritis Is Superior to Platelet-Rich Plasma or Hyaluronic Acid Alone in Inhibiting Inflammation and Improving Pain and Function. Arthroscopy. 2021;37(3):903-915. doi:10.1016/j.arthro.2020.10.013
2. Zhao J, Huang H, Liang G, Zeng LF, Yang W, Liu J. Effects and Safety of the Combination of Platelet-Rich Plasma (PRP) and Hyaluronic Acid (HA) in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. BMC Musculoskelet Disord. 2020;21(1):224. doi:10.1186/s12891-020-03262-w
3. Baria MR, Vasileff WK, Borchers J, DiBartola A, Flanigan DC, Plunkett E, Magnussen RA. Treating Knee Osteoarthritis With Platelet-Rich Plasma and Hyaluronic Acid Combination Therapy: A Systematic Review. Am J Sports Med. 2022;50(1):273-281. doi:10.1177/0363546521998010
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
